INDUCTION THERAPY WITH HIGH-DOSE CYTARABINE AND ANTHRACYCLINES IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA

被引：0
|
作者：
Gil, Perez Angela [1 ]
Vazquez, Ramo Alejandro [1 ]
De Rojas, de Pablo Teresa [2 ]
Torralba, Gomez de Suso Miguel [1 ]
Nuevo, Lopez Irene [1 ]
Subira, Perez Dolores [1 ]
Merchan, Munoz Beatriz [1 ]
Perez, Ortega Alba [1 ]
De Miguel, Llorente Dunia [1 ]
机构：
[1] Hosp Univ Guadalajara, Guadalajara, Spain
[2] Hosp Infantil Univ Nino Jesus, Madrid, Spain
来源：
HAEMATOLOGICA | 2020年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB-040
引用
收藏
页码：384 / 385
页数：2
相关论文
共 50 条
  • [1] High-dose cytarabine induction for acute myeloid leukemia
    Shepherd, JD
    Barnett, MJ
    Phillips, GL
    [J]. BLOOD, 1996, 88 (02) : 754 - 754
  • [2] High-Dose Cytarabine (HiDAC) Improves the Cure Rate of Patients with Newly Diagnosed Acute Myeloid Leukemia (AML): Is It Better to be Given As Induction Therapy or As Consolidation Therapy?
    Schwarer, Anthony P.
    Wight, Joel
    Jackson, Kathryn
    Beligaswatte, Ashanka Mahilal
    Butler, Jason P.
    Kennedy, Glen
    Martin, Louisa
    Lewis, Ian D.
    Hiwase, Devendra
    Zantomio, Daniela
    He, Simon Z.
    Grigg, Andrew
    Morris, Kirk
    Mollee, Peter
    Marlton, Paula
    [J]. BLOOD, 2016, 128 (22)
  • [3] A randomized study of high-dose cytarabine in induction in acute myeloid leukemia
    Bishop, JF
    Matthews, JP
    Young, GA
    Szer, J
    Gillett, A
    Joshua, D
    Bradstock, K
    Enno, A
    Wolf, MM
    Fox, R
    Cobcroft, R
    Herrmann, R
    VanDerWeyden, M
    Lowenthal, RM
    Page, F
    Garson, OM
    Juneja, S
    [J]. BLOOD, 1996, 87 (05) : 1710 - 1717
  • [4] A clinical report on high-dose cytarabine therapy for children with acute myeloid leukemia
    Wu, Ziliang
    Wu, Zelin
    Zou, Yawei
    Guan, Jingming
    Wu, Shangzhi
    Chen, Dehui
    [J]. MOLECULAR AND CLINICAL ONCOLOGY, 2022, 17 (05)
  • [5] Comparison of consolidation strategies in acute myeloid leukemia: high-dose cytarabine alone versus intermediate-dose cytarabine combined with anthracyclines
    Dae Sik Kim
    Ka-Won Kang
    Se Ryeon Lee
    Yong Park
    Hwa Jung Sung
    Seok Jin Kim
    Chul Won Choi
    Byung Soo Kim
    [J]. Annals of Hematology, 2015, 94 : 1485 - 1492
  • [6] Etoposide and mitoxantrone in newly diagnosed acute myeloid leukemia patients with persistent leukemia after a course of induction therapy with cytarabine and idarubicin
    McHayleh, W. M.
    Redner, R.
    Sehgal, R.
    Raptis, A.
    Agha, M.
    Natale, J.
    Luong, T.
    Schlesselman, J. J.
    Foon, K.
    Boyiadzis, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [7] Comparison of consolidation strategies in acute myeloid leukemia: high-dose cytarabine alone versus intermediate-dose cytarabine combined with anthracyclines
    Kim, Dae Sik
    Kang, Ka-Won
    Lee, Se Ryeon
    Park, Yong
    Sung, Hwa Jung
    Kim, Seok Jin
    Choi, Chul Won
    Kim, Byung Soo
    [J]. ANNALS OF HEMATOLOGY, 2015, 94 (09) : 1485 - 1492
  • [8] Induction chemotherapy with high-dose cytarabine and mitoxantrone in elderly acute myeloid leukemia (AML) patients.
    Ramanathan, Muthalagu
    Cerny, Jan
    Raffel, Glen
    Walsh, William Vincent
    Woda, Bruce
    Miron, Patricia
    Nath, Rajneesh
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [9] Idarubicin, high-dose cytarabine and etoposide for induction of remission in acute myeloid leukemia.
    Singhal, S
    Powles, R
    Treleaven, J
    Horton, C
    Hamblin, M
    Zomas, A
    Prendiville, J
    Saso, R
    Mackay, H
    Milan, S
    Mehta, J
    [J]. BLOOD, 1995, 86 (10) : 2039 - 2039
  • [10] Topotecan Plus Cytarabine: An Effective and Safe Induction Regimen for Newly Diagnosed Acute Myeloid Leukemia in Patients with Cardiac Contra-Indication to Anthracyclines
    Marcault, Clemence
    Venton, Geoffroy
    Gastaud, Lauris
    Mannone, Lionel
    Rey, Jerome
    D'Incan, Evelyne
    Saillard, Colombe
    Charbonnier, Aude
    Raynaud, Sophie
    Vey, Norbert
    Cluzeau, Thomas
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S214 - S214
12345